Found 8 matching trials
Phase 2 Study of AT13387 (Onalespib) in ALK+ ALCL, MCL, and BCL-6+ DLBCL PHASE2 This phase II trial studies how well onalespib works in treating patients w...
Show More Location
Los Angeles County-USC Medical Center
Learn More & Join Trial
Onalespib and Paclitaxel in Treating Patients With Advanced Triple Negative Breast Cancer PHASE1 This phase Ib trial studies the side effects and best dose onalespib when g...
Show More Location
University of Kentucky/Markey Cancer Center
Learn More & Join Trial
Olaparib and Onalespib in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Recurrent Ovarian, Fallopian Tube, Primary Peritoneal, or Triple-Negative Breast Cancer PHASE1 This phase I trial studies the side effects and best dose of olaparib and o...
Show More Location
Mayo Clinic Hospital in Arizona
Learn More & Join Trial
A Study of HSP90 Inhibitor AT13387 Alone or in Combination With Abiraterone Acetate PHASE1 A 2-part, Phase 1-2, open-label, parallel group, randomized study in patien...
Show More Location
University of California, Los Angeles Institute of Urologic Oncology
Learn More & Join Trial
Onalespib, Dabrafenib, and Trametinib in Treating Patients With BRAF-Mutant Melanoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery PHASE1 This phase I trial studies the side effects and best dose of onalespib when...
Show More Location
Massachusetts General Hospital Cancer Center
Learn More & Join Trial
Onalespib in Treating Patients With Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck Receiving Radiation Therapy and Cisplatin PHASE1 This phase I trial studies the side effects and best dose of onalespib when...
Show More Learn More & Join Trial
Onalespib and CDKI AT7519 in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery PHASE1 This phase I trial studies the side effects and best dose of onalespib and ...
Show More Location
MedStar Georgetown University Hospital
Learn More & Join Trial
Erlotinib Hydrochloride and Onalespib Lactate in Treating Patients With Recurrent or Metastatic EGFR-Mutant Non-small Cell Lung Cancer PHASE1 This phase I/II trial studies the side effects and best dose of onalespib l...
Show More Location
City of Hope Comprehensive Cancer Center
Learn More & Join Trial